FreeTender
Accepting bidstenderSpain

Contrato de Prestación de Servicios de Realización de Pruebas de Resonancia Magnética Cerebral en el Marco del Proyecto ICI23/00032 Less-Ad “a Phase III, Randomized, Double-Blinded Study of the Efficacy and Safety of Levetiracetam to Prevent Seizures in Symptomatic Alzheimer'S Disease in Adults with Down Syndrome” (IIBSP-LEV-2024-86) para la Fundació Institut de Recerca Hospital de la Santa Creu I

Issued by Fundació Privada Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (Departament de Salut) · via Contractació pública — Catalonia (Spain)

Verify & apply on the official portal →
Published
30 Oct 2026
Closes
16 Nov 2026, 13:00 UTC
Value
EUR 25,600
Reference
LICIR-OS 26/56
Location
Madrid, Catalonia, Spain
Sector
Healthcare & Pharma
Type
services

At a glance

Fundació Privada Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (Departament de Salut) in Madrid, Spain has published a tender in healthcare & pharma: “Contrato de Prestación de Servicios de Realización de Pruebas de Resonancia Magnética Cerebral en el Marco del Proyecto ICI23/00032 Less-Ad “a Phase III, Randomized, Double-Blinded Study of the Efficacy and Safety of Levetiracetam to Prevent Seizures in Symptomatic Alzheimer'S Disease in Adults with Down Syndrome” (IIBSP-LEV-2024-86) para la Fundació Institut de Recerca Hospital de la Santa Creu I”. Submissions close on 16 November 2026, 16 days from today. The stated value is EUR 25,600. Quote reference LICIR-OS 26/56 in any correspondence with the buyer. FreeTender has recorded 2 notices from this buyer since 2026, 1 of them currently open. There are 316 open healthcare & pharma notices in Spain on FreeTender. Bids are submitted to the buyer through Contractació pública — Catalonia (Spain), not through FreeTender.

Details

El presente procedimiento de licitación, tiene por objeto definir las características para llevar a cabo la prestación de los “servicios de realización de pruebas de resonancia magnética cerebral en el marco del Proyecto ICI23/00032 LESS-AD “A phase III, randomized, double-blinded study of the efficacy and safety of Levetiracetam to prevent Seizures in Symptomatic Alzheimer's Disease in adults with Down syndrome” (IIBSP-LEV-2024-86) para la Fundació Institut de Recerca de l’Hospital de la Santa Creu i San Pau” (IR Sant Pau).

Contracting body: Fundació Privada Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Department / entity: Departament de Salut

Administration: Departaments i sector públic de la Generalitat de Catalunya

File number: LICIR-OS 26/56

Contract type: Serveis

Procedure: Obert simplificat

Processing: Ordinària

Duration: 01/01/2027 a 31/12/2027

Place of execution: Madrid

NUTS: ES300

CPV: 85111000-0

Tender budget excl. VAT: EUR 25,600.00

Tender budget incl. VAT: EUR 30,976.00

Estimated value: EUR 25,600.00

Submission deadline (local time): 16/11/2026 14:00

Electronic submission tool: Sobre digital

Funding: FEDER (Fons europeu de desenvolupament regional)

Context for bidders

We hold 2 notices from Fundació Privada Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (Departament de Salut), going back to September 2026 — 1 of them still open. They buy mostly in Facility Management & Cleaning and Healthcare & Pharma. There are 316 open Healthcare & Pharma tenders in Spain. This one closes in 16 days.

Before you bid on this tender

A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.

  • Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
  • Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
  • Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
  • Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
  • Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
  • Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
Common bidding mistakes to avoid →Writing a winning proposal

More Healthcare & Pharma tenders

All Healthcare & Pharma tenders →

FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.

Verify & apply on the official portal →